A Study of SHR-3821 Injection in Subjects With Advanced Solid Tumors

NCT06618651 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SHR-3821 injection

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.